A study published in Blood Advances demonstrates that patients with blood cancers experienced a significant improvement in their reported well-being six months after receiving CAR T-cell therapy.
The Harrington Discovery Institute at University Hospitals and the American Society for Clinical Investigation have awarded Owen Witte with the twelfth annual Harrington Prize for Innovation in Medicine.
